{
    "document_id": "D-2025-3777",
    "LinkTitle": "D-2025-3777",
    "file_name": "D-2025-3777.pdf",
    "file_path": "/Users/JADEPOTTER5/Downloads/DMP-MT/processed_data/pdfs_new/org_pdfs/D-2025-3777.pdf",
    "metadata": {
        "title": "Evaluating Methodological Integrity in Reconsolidation Research: A Systematic Review",
        "author": "N/A",
        "num_pages": 6
    },
    "content": {
        "full_text": "Evaluating Methodological Integrity in Reconsolidation Research: A Systematic Review\nEvaluating Methodological Integrity in Reconsolidation Research: A Systematic Review\nResearch Data Summary\nResearch Data Summary\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For\neach dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know\neach dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know\nwhat data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type\nwhat data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type\nof the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data.\nof the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data.\nDataset\nname / ID\nDescription\nNew or\nreuse\nDigital\nor\nPhysical\ndata\nData Type\nFile\nformat\nData\nvolume\nPhysical\nvolume\nIncluded\nRCT\nMetadata\nData extracted from eligible RCTs, including\nsample size, intervention type, memory\nreactivation procedure, outcomes,\npreregistration details\nReused\nDigital\nNumerical and textual:\nObservational\nmetadata\n.xlsx,\n.csv\n~50MB\nx\nQuality\nAssessment\nData\nRoB 2 assessments for each RCT, including\ndomain-level judgments and overall bias\nNewly\nGenerated\nDigital\nNumerical and textual:\nEvaluation data\n.xlsx,\n.csv,\n.docx\n~10MB\nx\nProtocol\nAdherence\nRatings\nData on preregistration compliance, outcome\nreporting, and methodological deviations\nNewly\nGenerated\nDigital\nNumerical and textual:\nQualitative and\ncategorical\n.csv,\n.docx\n~10MB\nx\nEffect Size\nCalculations\nExtracted or calculated effect sizes (e.g.,\nCohen’s d) and CI for symptom reduction\nNewly\nGenerated\nDigital\nNumerical:\nQuantitative/statistical\n.xlsx,\n.R\n~10MB\nx\nNarrative\nNotes\nObservational summaries and qualitative\nsynthesis notes during review\nNewly\nGenerated\nDigital\nTextual\n.docx\n~10MB\nx\nCovidence\nScreening\nLogs\nScreening decisions, reviewer agreement,\ninclusion/exclusion logs\nNewly\nGenerated\nDigital\nTextual: Process logs\n.csv,\n.docx\n~10MB\nx\n \n \n \n \n \n \n \n \nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per\nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per\ndataset or data type:\ndataset or data type:\nPublished RCTs retrieved from: PubMed, Embase, PsycINFO(via OVID), CENTRAL, Web of Science, ClinicalTrials.gov\nPersistent IDs: DOIs of each included study will be collected and documented per record.\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If\nso, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number.\nso, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number.\nNo\nNo primary data will be collected from human participants. Only secondary data (published or preregistered RCTs) will be\nanalyzed.\nNo ethical approval required for reuse of publicly available, published data.\nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven\nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven\nor UZ Leuven privacy register number (G or S number).\nor UZ Leuven privacy register number (G or S number).\nNo\nNo personal data will be processed. \nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n1 of 6\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?\n If so, please comment per dataset or data type where appropriate. \n If so, please comment per dataset or data type where appropriate. \nNo\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer\nagreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what\nagreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what\nrestrictions are in place.\nrestrictions are in place.\nNo\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you\n(re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted.\n(re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted.\nNo\nAll reused data is from published articles. Proper citation (including DOIs) will be maintained.\nNo ownership or intellectual property rights issues apply.\nDocumentation and Metadata\nDocumentation and Metadata\nClearly describe what approach will be followed to capture the accompanying information necessary to keep \nClearly describe what approach will be followed to capture the accompanying information necessary to keep \ndata\ndata\nunderstandable and usable\nunderstandable and usable\n, for yourself and others, now and in the future (e.g. in terms of documentation levels and types\n, for yourself and others, now and in the future (e.g. in terms of documentation levels and types\nrequired, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nrequired, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nTo ensure that all datasets are understandable, transparent, and reusable both during the project and after its completion, the\nfollowing documentation practices will be implemented:\n1\n. \nREADME Files:\nREADME Files:\nA dedicated README file will accompany each dataset or dataset folder.\nEach README will contain:\nTitle and short description\nTitle and short description\n of the dataset (e.g., “Effect Size Calculations from Reconsolidation-Based RCTs”).\nDate of creation or update\nDate of creation or update\n, version number, and author(s) responsible for that dataset.\nPurpose of the dataset\nPurpose of the dataset\n (e.g., \"Contains all extracted symptom effect sizes used for meta-analysis\").\nDetailed explanation of each variable\nDetailed explanation of each variable\n or column in the dataset (e.g., “effect_size_d = Cohen’s d; group_n1 = sample\nsize of intervention group”).\nUnits of measurement\nUnits of measurement\n, missing data codes (e.g., NA, NULL), and how they were handled.\nSoftware used to create or process the data\nSoftware used to create or process the data\n (e.g., “R v4.3.1 with metafor package”).\nReference to related documents\nReference to related documents\n, such as the data extraction form or codebook.\nInstructions for re-use\nInstructions for re-use\n2\n. \nCodebook (.tsv or .xlsx format):\nCodebook (.tsv or .xlsx format):\nA structured \ncodebook\ncodebook\n will be created for the main data extraction sheet (i.e., the metadata extracted from RCTs).\nThis file will contain:\nVariable names\nVariable names\nVariable labels\nVariable labels\nData type\nData type\n (e.g., string, integer, categorical)\nValue labels\nValue labels\n (e.g., “1 = pharmacological; 2 = behavioral”)\n3\n. \nCovidence Logs:\nCovidence Logs:\nCovidence will be used for title/abstract screening, full-text screening, and conflict resolution.\nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n2 of 6\nExported logs from Covidence (in .csv or .docx/.pdf format) will document:\nInclusion/exclusion decisions\nInclusion/exclusion decisions\nReviewer agreement statistics\nReviewer agreement statistics\nReasons for exclusion\nReasons for exclusion\nTimestamps and reviewer IDs\nTimestamps and reviewer IDs\n4\n. \nZotero Metadata Archive:\nZotero Metadata Archive:\nAll references (included and excluded studies) will be organized in a \nZotero library\nZotero library\n, tagged by screening status (e.g.,\n“included_fulltext”, “excluded_population”), with notes detailing inclusion/exclusion justifications.\nEach item in Zotero will include:\nComplete citation\nPersistent identifier (e.g., DOI)\nPDF attachment (where available)\nLink to ClinicalTrials.gov or OSF registration (where applicable)\nManual notes on key methodological aspects (e.g., reactivation method, intervention timing)\n5\n. \nPreregistration Adherence Logs:\nPreregistration Adherence Logs:\nA separate documentation file (e.g., preregistration_compliance.docx) will be maintained, summarizing:\nWhether the study was preregistered\nWhich registry it was found in (e.g., ClinicalTrials.gov, WHO, OSF)\nWhether primary/secondary outcomes were reported as planned\nWhether any deviations were explained or justified\n6\n. \nReconsolidation Criteria Adherence Assessment Sheet (.xlsx):\nReconsolidation Criteria Adherence Assessment Sheet (.xlsx):\nA dedicated document (reconsolidation_criteria_assessment.xlsx) will be created to systematically evaluate each\nincluded RCT against the predefined\n reconsolidation criteria\n reconsolidation criteria\n outlined in the protocol (e.g., Memory Consolidation,\nReactivation, Post-Reactivation Intervention Timing, etc.).\nFor each study, reviewers will indicate:\nWhether each criterion is fulfilled\nWhether each criterion is fulfilled\n (Yes/No/Unclear),\nSupporting evidence from the text\nSupporting evidence from the text\n (e.g., quotes or figure references),\nReviewer comments or justifications\nReviewer comments or justifications\n, and\nAn overall \nadherence score or classification\nadherence score or classification\n (e.g., High, Moderate, Low).\n \nAny update to datasets (e.g., adding new studies, corrections) will be logged with date, reason for change, and author initials.\nWill a metadata standard be used to make it easier to \nWill a metadata standard be used to make it easier to \nfind and reuse the data\nfind and reuse the data\n?  \n?  \nIf so, please specify which metadata standard will be used. \nIf so, please specify which metadata standard will be used. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nYes\nTo ensure clarity, transparency, and future reusability of all datasets, this project will follow the \nPRISMA 2020 reporting standard\nPRISMA 2020 reporting standard\nand maintain structured documentation throughout the review process.\nAll documentation and metadata associated with this project will align with the \nPRISMA 2020 Statement\nPRISMA 2020 Statement\n guidelines for\nsystematic reviews. This includes:\nEligibility Criteria Documentation\nEligibility Criteria Documentation\nA detailed .docx file outlining all inclusion/exclusion criteria used during study selection, consistent with PRISMA Item 5.\nSearch Strategy Documentation\nSearch Strategy Documentation\nA .pdf file containing the full search strings for each database, with syntax tailored to each platform (PubMed, Embase,\nPsycINFO, CENTRAL, etc.), per PRISMA Item 7.\nStudy Selection and Flow Diagram\nStudy Selection and Flow Diagram\nA PRISMA 2020-compliant flowchart (.png and .pdf) showing the number of studies at each stage of screening, generated\nvia Covidence or manually created in accordance with PRISMA Item 16a.\nList of Excluded Studies\nList of Excluded Studies\nA .csv file listing all full-text studies excluded after screening, with justifications for exclusion (Item 16b).\nData Extraction File (Main Dataset)\nData Extraction File (Main Dataset)\nAn .xlsx file that includes all key extracted variables for included RCTs:\nAuthor, year, country\nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n3 of 6\nPopulation and sample size\nIntervention type (pharmacological/behavioral)\nMemory reactivation method\nTiming of intervention\nSymptom measures and outcomes\nAdherence to reconsolidation criteria\nPreregistration status and deviations\nEffect sizes and statistical outcome\nData Storage & Back-up during the Research Project\nData Storage & Back-up during the Research Project\nWhere will the data be stored?\nWhere will the data be stored?\nSharepoint online\nOther (specify below)\nKU Leuven OneDrive and KU Leuven secured servers.\nHow will the data be backed up?\nHow will the data be backed up?\nStandard back-up provided by KU Leuven ICTS for my storage solution\nIs there currently sufficient storage & backup capacity during the project? \nIs there currently sufficient storage & backup capacity during the project? \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nYes\nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nAccess is already restricted to research team via KU Leuven institutional login. Files will be encrypted where necessary.\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nCovered by institutional infrastructure, no additional costs.\nData Preservation after the end of the Research Project\nData Preservation after the end of the Research Project\nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of\nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of\nthe project? \nthe project? \nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget\nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget\nissues, institutional policies...).\nissues, institutional policies...).\nAll data will be preserved for 10 years according to KU Leuven RDM policy\nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n4 of 6\nWhere will these data be archived (stored and curated for the long-term)? \nWhere will these data be archived (stored and curated for the long-term)? \nKU Leuven RDR\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nNo costs expected; repositories are free for academic use or covered by institution.\nData Sharing and Reuse\nData Sharing and Reuse\nWill the data (or part of the data) be made available for reuse after/during the project?  \nWill the data (or part of the data) be made available for reuse after/during the project?  \nPlease explain per dataset or data type which data will be made available.\nPlease explain per dataset or data type which data will be made available.\nYes, as open data\nWe will share\nWe will share\n:\nExtracted datasets\nRisk of bias scores\nChecklist adherence ratings\nEffect sizes\nSearch strategy\nIf access is restricted, please specify who will be able to access the data and under what conditions. \nIf access is restricted, please specify who will be able to access the data and under what conditions. \nIt will be public, via OSF (or similar open access platform) and linked to publication (DOI).\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party,\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party,\nlegal restrictions)? \nlegal restrictions)? \nPlease explain per dataset or data type where appropriate.\nPlease explain per dataset or data type where appropriate.\nNo\nNone. However, individual RCT full-texts will not be redistributed.\nWhere will the data be made available?  \nWhere will the data be made available?  \nIf already known, please provide a repository per dataset or data type.\nIf already known, please provide a repository per dataset or data type.\nKU Leuven RDR (Research Data Repository)\nOther data repository (specify below)\nOSF (\nhttps://osf.io\n), Lirias (KU Leuven), PROSPERO (registration)\nWhen will the data be made available? \nWhen will the data be made available? \nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n5 of 6\nUpon publication of research results\nWhich data usage licenses are you going to provide? \nWhich data usage licenses are you going to provide? \nIf none, please explain why. \nIf none, please explain why. \nCC-BY 4.0 (data)\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please\nprovide it here. \nprovide it here. \n​​Yes, a PID will be added upon deposit in a data repository\nWhat are the expected costs for data sharing? How will these costs be covered?  \nWhat are the expected costs for data sharing? How will these costs be covered?  \nNone expected for sharing; covered by open access platforms.\nResponsibilities\nResponsibilities\nWho will manage data documentation and metadata during the research project? \nWho will manage data documentation and metadata during the research project? \nLora \nČ\nuljak (\nlora.culjak@kuleuven.be\n)\nadditionally: Tom Beckers (tom.beckers@kuleuven.be)\nWho will manage data storage and backup during the research project? \nWho will manage data storage and backup during the research project? \nLora \nČ\nuljak (\nlora.culjak@kuleuven.be\n)\nadditionally: Tom Beckers (tom.beckers@kuleuven.be)\nWho will manage data preservation and sharing? \nWho will manage data preservation and sharing? \nLora \nČ\nuljak (\nlora.culjak@kuleuven.be\n)\nadditionally: Tom Beckers (tom.beckers@kuleuven.be)\nWho will update and implement this DMP? \nWho will update and implement this DMP? \nLora \nČ\nuljak (\nlora.culjak@kuleuven.be\n)\nadditionally: Tom Beckers (tom.beckers@kuleuven.be)\nCreated using DMPonline.be. Last modiﬁed 04 April 2025\n6 of 6"
    },
    "clean_full_text": "Evaluating Methodological Integrity in Reconsolidation Research: A Systematic Review Evaluating Methodological Integrity in Reconsolidation Research: A Systematic Review Research Data Summary Research Data Summary List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. Dataset name / ID Description New or reuse Digital or Physical data Data Type File format Data volume Physical volume Included RCT Metadata Data extracted from eligible RCTs, including sample size, intervention type, memory reactivation procedure, outcomes, preregistration details Reused Digital Numerical and textual: Observational metadata .xlsx, .csv ~50MB x Quality Assessment Data RoB 2 assessments for each RCT, including domain-level judgments and overall bias Newly Generated Digital Numerical and textual: Evaluation data .xlsx, .csv, .docx ~10MB x Protocol Adherence Ratings Data on preregistration compliance, outcome reporting, and methodological deviations Newly Generated Digital Numerical and textual: Qualitative and categorical .csv, .docx ~10MB x Effect Size Calculations Extracted or calculated effect sizes (e.g., Cohen’s d) and CI for symptom reduction Newly Generated Digital Numerical: Quantitative/statistical .xlsx, .R ~10MB x Narrative Notes Observational summaries and qualitative synthesis notes during review Newly Generated Digital Textual .docx ~10MB x Covidence Screening Logs Screening decisions, reviewer agreement, inclusion/exclusion logs Newly Generated Digital Textual: Process logs .csv, .docx ~10MB x If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data type: dataset or data type: Published RCTs retrieved from: PubMed, Embase, PsycINFO(via OVID), CENTRAL, Web of Science, ClinicalTrials.gov Persistent IDs: DOIs of each included study will be collected and documented per record. Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number. so, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number. No No primary data will be collected from human participants. Only secondary data (published or preregistered RCTs) will be analyzed. No ethical approval required for reuse of publicly available, published data. Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ Leuven privacy register number (G or S number). or UZ Leuven privacy register number (G or S number). No No personal data will be processed. Created using DMPonline.be. Last modiﬁed 04 April 2025 1 of 6 Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, please comment per dataset or data type where appropriate. If so, please comment per dataset or data type where appropriate. No Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what agreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. restrictions are in place. No Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. No All reused data is from published articles. Proper citation (including DOIs) will be maintained. No ownership or intellectual property rights issues apply. Documentation and Metadata Documentation and Metadata Clearly describe what approach will be followed to capture the accompanying information necessary to keep Clearly describe what approach will be followed to capture the accompanying information necessary to keep data data understandable and usable understandable and usable , for yourself and others, now and in the future (e.g. in terms of documentation levels and types , for yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). required, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). To ensure that all datasets are understandable, transparent, and reusable both during the project and after its completion, the following documentation practices will be implemented: 1 . README Files: README Files: A dedicated README file will accompany each dataset or dataset folder. Each README will contain: Title and short description Title and short description of the dataset (e.g., “Effect Size Calculations from Reconsolidation-Based RCTs”). Date of creation or update Date of creation or update , version number, and author(s) responsible for that dataset. Purpose of the dataset Purpose of the dataset (e.g., \"Contains all extracted symptom effect sizes used for meta-analysis\"). Detailed explanation of each variable Detailed explanation of each variable or column in the dataset (e.g., “effect_size_d = Cohen’s d; group_n1 = sample size of intervention group”). Units of measurement Units of measurement , missing data codes (e.g., NA, NULL), and how they were handled. Software used to create or process the data Software used to create or process the data (e.g., “R v4.3.1 with metafor package”). Reference to related documents Reference to related documents , such as the data extraction form or codebook. Instructions for re-use Instructions for re-use 2 . Codebook (.tsv or .xlsx format): Codebook (.tsv or .xlsx format): A structured codebook codebook will be created for the main data extraction sheet (i.e., the metadata extracted from RCTs). This file will contain: Variable names Variable names Variable labels Variable labels Data type Data type (e.g., string, integer, categorical) Value labels Value labels (e.g., “1 = pharmacological; 2 = behavioral”) 3 . Covidence Logs: Covidence Logs: Covidence will be used for title/abstract screening, full-text screening, and conflict resolution. Created using DMPonline.be. Last modiﬁed 04 April 2025 2 of 6 Exported logs from Covidence (in .csv or .docx/.pdf format) will document: Inclusion/exclusion decisions Inclusion/exclusion decisions Reviewer agreement statistics Reviewer agreement statistics Reasons for exclusion Reasons for exclusion Timestamps and reviewer IDs Timestamps and reviewer IDs 4 . Zotero Metadata Archive: Zotero Metadata Archive: All references (included and excluded studies) will be organized in a Zotero library Zotero library , tagged by screening status (e.g., “included_fulltext”, “excluded_population”), with notes detailing inclusion/exclusion justifications. Each item in Zotero will include: Complete citation Persistent identifier (e.g., DOI) PDF attachment (where available) Link to ClinicalTrials.gov or OSF registration (where applicable) Manual notes on key methodological aspects (e.g., reactivation method, intervention timing) 5 . Preregistration Adherence Logs: Preregistration Adherence Logs: A separate documentation file (e.g., preregistration_compliance.docx) will be maintained, summarizing: Whether the study was preregistered Which registry it was found in (e.g., ClinicalTrials.gov, WHO, OSF) Whether primary/secondary outcomes were reported as planned Whether any deviations were explained or justified 6 . Reconsolidation Criteria Adherence Assessment Sheet (.xlsx): Reconsolidation Criteria Adherence Assessment Sheet (.xlsx): A dedicated document (reconsolidation_criteria_assessment.xlsx) will be created to systematically evaluate each included RCT against the predefined reconsolidation criteria reconsolidation criteria outlined in the protocol (e.g., Memory Consolidation, Reactivation, Post-Reactivation Intervention Timing, etc.). For each study, reviewers will indicate: Whether each criterion is fulfilled Whether each criterion is fulfilled (Yes/No/Unclear), Supporting evidence from the text Supporting evidence from the text (e.g., quotes or figure references), Reviewer comments or justifications Reviewer comments or justifications , and An overall adherence score or classification adherence score or classification (e.g., High, Moderate, Low). Any update to datasets (e.g., adding new studies, corrections) will be logged with date, reason for change, and author initials. Will a metadata standard be used to make it easier to Will a metadata standard be used to make it easier to find and reuse the data find and reuse the data ? ? If so, please specify which metadata standard will be used. If so, please specify which metadata standard will be used. If not, please specify which metadata will be created to make the data easier to find and reuse. If not, please specify which metadata will be created to make the data easier to find and reuse. Yes To ensure clarity, transparency, and future reusability of all datasets, this project will follow the PRISMA 2020 reporting standard PRISMA 2020 reporting standard and maintain structured documentation throughout the review process. All documentation and metadata associated with this project will align with the PRISMA 2020 Statement PRISMA 2020 Statement guidelines for systematic reviews. This includes: Eligibility Criteria Documentation Eligibility Criteria Documentation A detailed .docx file outlining all inclusion/exclusion criteria used during study selection, consistent with PRISMA Item 5. Search Strategy Documentation Search Strategy Documentation A .pdf file containing the full search strings for each database, with syntax tailored to each platform (PubMed, Embase, PsycINFO, CENTRAL, etc.), per PRISMA Item 7. Study Selection and Flow Diagram Study Selection and Flow Diagram A PRISMA 2020-compliant flowchart (.png and .pdf) showing the number of studies at each stage of screening, generated via Covidence or manually created in accordance with PRISMA Item 16a. List of Excluded Studies List of Excluded Studies A .csv file listing all full-text studies excluded after screening, with justifications for exclusion (Item 16b). Data Extraction File (Main Dataset) Data Extraction File (Main Dataset) An .xlsx file that includes all key extracted variables for included RCTs: Author, year, country Created using DMPonline.be. Last modiﬁed 04 April 2025 3 of 6 Population and sample size Intervention type (pharmacological/behavioral) Memory reactivation method Timing of intervention Symptom measures and outcomes Adherence to reconsolidation criteria Preregistration status and deviations Effect sizes and statistical outcome Data Storage & Back-up during the Research Project Data Storage & Back-up during the Research Project Where will the data be stored? Where will the data be stored? Sharepoint online Other (specify below) KU Leuven OneDrive and KU Leuven secured servers. How will the data be backed up? How will the data be backed up? Standard back-up provided by KU Leuven ICTS for my storage solution Is there currently sufficient storage & backup capacity during the project? Is there currently sufficient storage & backup capacity during the project? If no or insufficient storage or backup capacities are available, explain how this will be taken care of. If no or insufficient storage or backup capacities are available, explain how this will be taken care of. Yes How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? Access is already restricted to research team via KU Leuven institutional login. Files will be encrypted where necessary. What are the expected costs for data storage and backup during the research project? How will these costs be covered? What are the expected costs for data storage and backup during the research project? How will these costs be covered? Covered by institutional infrastructure, no additional costs. Data Preservation after the end of the Research Project Data Preservation after the end of the Research Project Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional policies...). issues, institutional policies...). All data will be preserved for 10 years according to KU Leuven RDM policy Created using DMPonline.be. Last modiﬁed 04 April 2025 4 of 6 Where will these data be archived (stored and curated for the long-term)? Where will these data be archived (stored and curated for the long-term)? KU Leuven RDR What are the expected costs for data preservation during the expected retention period? How will these costs be covered? What are the expected costs for data preservation during the expected retention period? How will these costs be covered? No costs expected; repositories are free for academic use or covered by institution. Data Sharing and Reuse Data Sharing and Reuse Will the data (or part of the data) be made available for reuse after/during the project? Will the data (or part of the data) be made available for reuse after/during the project? Please explain per dataset or data type which data will be made available. Please explain per dataset or data type which data will be made available. Yes, as open data We will share We will share : Extracted datasets Risk of bias scores Checklist adherence ratings Effect sizes Search strategy If access is restricted, please specify who will be able to access the data and under what conditions. If access is restricted, please specify who will be able to access the data and under what conditions. It will be public, via OSF (or similar open access platform) and linked to publication (DOI). Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal restrictions)? legal restrictions)? Please explain per dataset or data type where appropriate. Please explain per dataset or data type where appropriate. No None. However, individual RCT full-texts will not be redistributed. Where will the data be made available? Where will the data be made available? If already known, please provide a repository per dataset or data type. If already known, please provide a repository per dataset or data type. KU Leuven RDR (Research Data Repository) Other data repository (specify below) OSF ( https://osf.io ), Lirias (KU Leuven), PROSPERO (registration) When will the data be made available? When will the data be made available? Created using DMPonline.be. Last modiﬁed 04 April 2025 5 of 6 Upon publication of research results Which data usage licenses are you going to provide? Which data usage licenses are you going to provide? If none, please explain why. If none, please explain why. CC-BY 4.0 (data) Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it here. provide it here. ​​Yes, a PID will be added upon deposit in a data repository What are the expected costs for data sharing? How will these costs be covered? What are the expected costs for data sharing? How will these costs be covered? None expected for sharing; covered by open access platforms. Responsibilities Responsibilities Who will manage data documentation and metadata during the research project? Who will manage data documentation and metadata during the research project? Lora Č uljak ( lora.culjak@kuleuven.be ) additionally: Tom Beckers (tom.beckers@kuleuven.be) Who will manage data storage and backup during the research project? Who will manage data storage and backup during the research project? Lora Č uljak ( lora.culjak@kuleuven.be ) additionally: Tom Beckers (tom.beckers@kuleuven.be) Who will manage data preservation and sharing? Who will manage data preservation and sharing? Lora Č uljak ( lora.culjak@kuleuven.be ) additionally: Tom Beckers (tom.beckers@kuleuven.be) Who will update and implement this DMP? Who will update and implement this DMP? Lora Č uljak ( lora.culjak@kuleuven.be ) additionally: Tom Beckers (tom.beckers@kuleuven.be) Created using DMPonline.be. Last modiﬁed 04 April 2025 6 of 6"
}